Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques.

Autor: Theel W; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Obesity Center CGG, Rotterdam, The Netherlands., Boxma-de Klerk BM; Department of Statistics and Education, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Dirksmeier-Harinck F; Department of Gastroenterology and Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., van Rossum EFC; Obesity Center CGG, Rotterdam, The Netherlands.; Department of Internal Medicine, Division of Endocrinology, Erasmus University Medical Center, Rotterdam, The Netherlands., Kanhai DA; Department of Pediatrics, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Apers J; Department of Bariatric Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., van Dalen BM; Department of Cardiology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus Medical Centre, Rotterdam, The Netherlands., Holleboom AG; Department of Vascular Medicine, Amsterdam UMC, Amsterdam, The Netherlands., Tushuizen ME; Department of Gastroenterology and Hepatology, Leiden UMC, Leiden, The Netherlands., Grobbee DE; Julius Centre for Health Science and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.; Julius Clinical, Zeist, The Netherlands., Wiebolt J; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Obesity Center CGG, Rotterdam, The Netherlands., Castro Cabezas M; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Department of Internal Medicine, Division of Endocrinology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Julius Clinical, Zeist, The Netherlands.

Publikováno v: Obesity reviews : an official journal of the International Association for the Study of Obesity [Obes Rev] 2022 Aug; Vol. 23 (8), pp. e13481. Date of Electronic Publication: 2022 Jun 12.

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease.

Autor: Kranendonk ME, de Kleijn DP, Kalkhoven E, Kanhai DA, Uiterwaal CS, van der Graaf Y, Pasterkamp G, Visseren FL; Department of Vascular Medicine, University Medical Centre Utrecht (UMCU), F02,126, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands. f.l.j.visseren@umcutrecht.nl.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2014 Feb 05; Vol. 13, pp. 37. Date of Electronic Publication: 2014 Feb 05.

Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease.

Autor: Kanhai DA; Department of Vascular Medicine, University Medical Center Utrecht (UMC Utrecht), Utrecht, The Netherlands., Visseren FL, van der Graaf Y, Schoneveld AH, Catanzariti LM, Timmers L, Kappelle LJ, Uiterwaal CS, Lim SK, Sze SK, Pasterkamp G, de Kleijn DP

Publikováno v: International journal of cardiology [Int J Cardiol] 2013 Oct 03; Vol. 168 (3), pp. 2358-63. Date of Electronic Publication: 2013 Feb 26.

Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposity.

Autor: Faber DR; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., van der Graaf Y, Westerink J, Kanhai DA, Monajemi H, Visseren FL

Publikováno v: European journal of clinical investigation [Eur J Clin Invest] 2013 Apr; Vol. 43 (4), pp. 369-78. Date of Electronic Publication: 2013 Feb 10.